Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 28, 2010

Repligen Strikes Five-Year Extension to Supply Protein A to GE Healthcare

  • Repligen entered into a five-year supply agreement with GE Healthcare for recombinant Protein A, a consumable used in the manufacture of mAbs. This agreement provides for Repligen to continue to be a strategic supplier to GE Healthcare through 2014.

    GE Healthcare sells chromatography products that incorporate Repligen's recombinant Protein A to the biopharmaceutical industry for the manufacture of mAbs.



Related content

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »